Efficacy and Safety of Simultaneous Integrated Boost Radiotherapy in HR/VHR Prostate Cancer With EPLNI

NHS England to offer targeted SABR radiotherapy for early prostate cancer, reducing treatment sessions from 20 to 5

NHS England will offer stereotactic radiotherapy (SABR) to thousands of men with early prostate cancer across all 48 radiotherapy centres wi

NHS to offer precision radiotherapy for prostate cancer, cutting treatment from 20 to 5 sessions

The NHS in England is rolling out precision radiotherapy (stereotactic ablative radiotherapy/SABR) for prostate cancer, reducing treatment s

Experimenteller Hirntumor-Impfstoff liefert ermutigende Langzeitergebnisse

Modellprojekt mit vorbereitendem Workshop zur Implementierung und Evaluierung einer Interventionsstrategie zur Verbesserung der Arzneimitteltherapiesicherheit (AMTS) bei Patientinnen und Patienten mit oraler Tumortherapie

Real-World EV Plus Pembro Success Seen in Urothelial Cancer

GE HealthCare and Mayo Clinic launch theranostics study to personalize prostate cancer treatment

GE HealthCare and Mayo Clinic have launched the MI-BET research collaboration, a theranostics study aimed at developing a more personalized